{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T20:44:02Z","timestamp":1780778642124,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T00:00:00Z","timestamp":1477872000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100013062","name":"G\u00e9nome Qu\u00e9bec","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008762","name":"Genome Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013739","name":"Pfizer Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013739","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Bernie O'Brien Post-Doctoral Fellowship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s40291-016-0238-8","type":"journal-article","created":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T14:39:19Z","timestamp":1477924759000},"page":"95-105","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Economic Evaluation of a Pharmacogenomics Test for Statin-Induced Myopathy in Cardiovascular High-Risk Patients Initiating a Statin"],"prefix":"10.1007","volume":"21","author":[{"given":"Dominic","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R.","family":"Guertin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ange Christelle","family":"Iliza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorella","family":"Fanton-Aita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"LeLorier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,31]]},"reference":[{"key":"238_CR1","unstructured":"Statistics Canada, Cholesterol levels of Canadians, 2009 to 2011. 2012. http:\/\/www.statcan.gc.ca\/pub\/82-625-x\/2012001\/article\/11732-eng.htm . Accessed 2013 06 08."},{"issue":"2","key":"238_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cjca.2012.11.032","volume":"29","author":"TJ Anderson","year":"2013","unstructured":"Anderson TJ, Gregoire J, Hegele RA, Couture P, Mancini GB, McPherson R, et al. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol. 2013;29(2):151\u201367. doi: 10.1016\/j.cjca.2012.11.032 .","journal-title":"Can J Cardiol."},{"key":"238_CR3","unstructured":"Adriana B. Are we overdosing on this \u2018wonder drug\u2019? The Globe and Mail. 2012. http:\/\/www.theglobeandmail.com\/life\/health-and-fitness\/health\/conditions\/are-we-overdosing-on-this-wonder-drug\/article4101464\/ . Accessed 29 janvier 2014."},{"issue":"3","key":"238_CR4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0735-1097(02)02030-2","volume":"40","author":"RC Pasternak","year":"2002","unstructured":"Pasternak RC, Smith SC Jr, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C, et al. ACC\/AHA\/NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol. 2002;40(3):567\u201372.","journal-title":"J Am Coll Cardiol."},{"key":"238_CR5","unstructured":"Chai C, James H. Working out \u2019til you\u2019re sick? Doctors warn of rhabdo, a deadly condition linked to over exercising. Global news, Canada, Montreal. 2014. http:\/\/globalnews.ca\/news\/1082282\/doctors-warn-of-rhabdo-a-deadly-condition-linked-to-over-exercising\/ . Accessed 23 Jan 2016."},{"issue":"3","key":"238_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ijcard.2011.07.048","volume":"159","author":"LS Rallidis","year":"2012","unstructured":"Rallidis LS, Fountoulaki K, Anastasiou-Nana M. Managing the underestimated risk of statin-associated myopathy. Int J Cardiol. 2012;159(3):169\u201376. doi: 10.1016\/j.ijcard.2011.07.048 .","journal-title":"Int J Cardiol."},{"issue":"3","key":"238_CR7","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ahj.2013.06.004","volume":"166","author":"WM Mampuya","year":"2013","unstructured":"Mampuya WM, Frid D, Rocco M, Huang J, Brennan DM, Hazen SL, et al. Treatment strategies in patients with statin intolerance: the Cleveland clinic experience. Am Heart J. 2013;166(3):597\u2013603. doi: 10.1016\/j.ahj.2013.06.004 .","journal-title":"Am Heart J."},{"issue":"3","key":"238_CR8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1517\/14740338.2011.540568","volume":"10","author":"TT Abd","year":"2011","unstructured":"Abd TT, Jacobson TA. Statin-induced myopathy: a review and update. Expert Opin Drug Saf. 2011;10(3):373\u201387. doi: 10.1517\/14740338.2011.540568 .","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"238_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ahj.2014.03.019","volume":"168","author":"HV Ganga","year":"2014","unstructured":"Ganga HV, Slim HB, Thompson PD. A systematic review of statin-induced muscle problems in clinical trials. Am Heart J. 2014;168(1):6\u201315. doi: 10.1016\/j.ahj.2014.03.019 .","journal-title":"Am Heart J"},{"key":"238_CR10","unstructured":"U.S. Food and Drug Administration. Guidance for industry: in vitro companion diagnostic devices. In: U.S. Department of Health and Human Services, editor. Washington, DC2014."},{"issue":"1","key":"238_CR11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/clpt.2012.57","volume":"92","author":"RA Wilke","year":"2012","unstructured":"Wilke RA, Ramsey LB, Johnson SG, Maxwell WD, McLeod HL, Voora D, et al. The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. Clin Pharmacol Ther. 2012;92(1):112\u20137. doi: 10.1038\/clpt.2012.57 .","journal-title":"Clin Pharmacol Ther."},{"issue":"86","key":"238_CR12","first-page":"45","volume":"16","author":"JP Kitzmiller","year":"2013","unstructured":"Kitzmiller JP, Binkley PF, Pandey SR, Suhy AM, Baldassarre D, Hartmann K. Statin pharmacogenomics: pursuing biomarkers for predicting clinical outcomes. Discov Med. 2013;16(86):45\u201351.","journal-title":"Discov Med."},{"key":"238_CR13","doi-asserted-by":"publisher","unstructured":"Stewart A. SLCO1B1 polymorphisms and statin-induced myopathy. PLoS Curr. 2013;5:ecurrents.eogt.d21e7f0c58463571bb0d9d3a19b82203. doi: 10.1371\/currents.eogt.d21e7f0c58463571bb0d9d3a19b82203 .","DOI":"10.1371\/currents.eogt.d21e7f0c58463571bb0d9d3a19b82203"},{"issue":"12","key":"238_CR14","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.jacc.2012.12.034","volume":"61","author":"KF Erickson","year":"2013","unstructured":"Erickson KF, Japa S, Owens DK, Chertow GM, Garber AM, Goldhaber-Fiebert JD. Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. J Am Coll Cardiol. 2013;61(12):1250\u20138. doi: 10.1016\/j.jacc.2012.12.034 .","journal-title":"J Am Coll Cardiol."},{"issue":"2","key":"238_CR15","first-page":"e331","volume":"16","author":"M Wagner","year":"2009","unstructured":"Wagner M, Goetghebeur M, Merikle E, Pandya A, Chu P, Taylor DC. Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in Canada. Can J Clin Pharmacol. 2009;16(2):e331\u201345.","journal-title":"Can J Clin Pharmacol."},{"issue":"3","key":"238_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.atherosclerosissup.2004.08.027","volume":"5","author":"TR Pedersen","year":"2004","unstructured":"Pedersen TR, Kjekshus J, Berg K, Haghfelt T, Faergeman O, Faergeman G, et al. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. Atheroscler Suppl. 2004;5(3):81\u20137. doi: 10.1016\/j.atherosclerosissup.2004.08.027 .","journal-title":"Atheroscler Suppl."},{"key":"238_CR17","unstructured":"Statistique Canada. Tables de mortalit\u00e9, Canada, provinces et territoires, 2009 \u00e0 2011. No 84-537-X au catalogue\u2014No 005 ISSN: 1910-3492. Ottawa, 2013."},{"issue":"21","key":"238_CR18","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1001\/archinte.162.21.2405","volume":"162","author":"MR Law","year":"2002","unstructured":"Law MR, Watt HC, Wald NJ. The underlying risk of death after myocardial infarction in the absence of treatment. Arch Intern Med. 2002;162(21):2405\u201310.","journal-title":"Arch Intern Med."},{"key":"238_CR19","unstructured":"Statistique Canada. Indice des prix \u00e0 la consommation, aper\u00e7u historique (1994 \u00e0 2014). Tableau 326-0021. Ottawa, 2015."},{"key":"238_CR20","unstructured":"R\u00e9gie de l\u2019assurance-m\u00e9dicament du Qu\u00e9bec. Manuel des m\u00e9decins omnipraticiens. Quebec City. 2014. http:\/\/www.ramq.gouv.qc.ca\/SiteCollectionDocuments\/professionnels\/manuels\/100-facturation-omnipraticiens\/maj79_acte_omni.pdf . Accessed 10 April 2014."},{"key":"238_CR21","unstructured":"R\u00e9gie de l\u2019assurance-m\u00e9dicament du Qu\u00e9bec. Liste des m\u00e9dicaments. Quebec City. 2014. https:\/\/www.prod.ramq.gouv.qc.ca\/DPI\/PO\/Commun\/PDF\/Liste_Med\/Liste_Med\/liste_med_2014_03_14_fr.pdf . Accessed 10 April 2014."},{"key":"238_CR22","doi-asserted-by":"crossref","unstructured":"Hauber AB, Garcia-Cebrian A, Kim Le T, Maas G, Das Gupta R. Population Health-State Utilities for Fibromyalgia in the United Kingdom ISPOR 11th Annual European Meeting; Madrid, 2008.","DOI":"10.1016\/S1098-3015(10)66218-3"},{"issue":"16","key":"238_CR23","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.jacc.2011.05.056","volume":"58","author":"BJ Kempen van","year":"2011","unstructured":"van Kempen BJ, Spronk S, Koller MT, Elias-Smale SE, Fleischmann KE, Ikram MA, et al. Comparative effectiveness and cost-effectiveness of computed tomography screening for coronary artery calcium in asymptomatic individuals. J Am Coll Cardiol. 2011;58(16):1690\u2013701. doi: 10.1016\/j.jacc.2011.05.056 .","journal-title":"J Am Coll Cardiol."},{"issue":"21","key":"238_CR24","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1001\/jama.292.21.2585","volume":"292","author":"DJ Graham","year":"2004","unstructured":"Graham DJ, Staffa JA, Shatin D, Andrade SE, Schech SD, La Grenade L, et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA. 2004;292(21):2585\u201390. doi: 10.1001\/jama.292.21.2585 .","journal-title":"JAMA."},{"issue":"1","key":"238_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/pds.1148","volume":"15","author":"H Cardinal","year":"2006","unstructured":"Cardinal H, Monfared AA, Dorais M, Lelorier J. The concept of the \u2018percent wasted patients\u2019 in preventive health strategies. Pharmacoepidemiol Drug Saf. 2006;15(1):57\u201361. doi: 10.1002\/pds.1148 .","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"6","key":"238_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1046\/j.1524-4733.2000.36006.x","volume":"3","author":"VS Catalan","year":"2000","unstructured":"Catalan VS, LeLorier J. Predictors of long-term persistence on statins in a subsidized clinical population. Value Health. 2000;3(6):417\u201326. doi: 10.1046\/j.1524-4733.2000.36006.x .","journal-title":"Value Health."},{"issue":"7","key":"238_CR27","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/S0828-282X(10)70413-X","volume":"26","author":"M Dorais","year":"2010","unstructured":"Dorais M, Chirovsky D, Ambegaonkar B, Sazonov V, Davies G, Grant S, et al. Utilization patterns of extended-release niacin in Canada: analysis of an administrative claims database. Can J Cardiol. 2010;26(7):e229\u201335.","journal-title":"Can J Cardiol"},{"issue":"1","key":"238_CR28","doi-asserted-by":"publisher","first-page":"e0146272","DOI":"10.1371\/journal.pone.0146272","volume":"11","author":"H Wouters","year":"2016","unstructured":"Wouters H, Van Dijk L, Geers HCJ, Winters NA, Van Geffen ECG, Stiggelbout AM, et al. Understanding statin non-adherence: knowing which perceptions and experiences matter to different patients. PLoS One. 2016;11(1):e0146272. doi: 10.1371\/journal.pone.0146272 .","journal-title":"PLoS One."},{"issue":"24","key":"238_CR29","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1002\/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0","volume":"15","author":"JP Higgins","year":"1996","unstructured":"Higgins JP, Whitehead A. Borrowing strength from external trials in a meta-analysis. Stat Med. 1996;15(24):2733\u201349. doi: 10.1002\/(SICI)1097-0258(19961230)15:24<2733:AID-SIM562>3.0.CO;2-0 .","journal-title":"Stat Med."},{"issue":"8","key":"238_CR30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0828-282X(10)70437-2","volume":"26","author":"KG Smolderen","year":"2010","unstructured":"Smolderen KG, Bell A, Lei Y, Cohen EA, Steg PG, Bhatt DL, et al. One-year costs associated with cardiovascular disease in Canada: insights from the REduction of Atherothrombosis for Continued Health (REACH) registry. Can J Cardiol. 2010;26(8):297\u2013305.","journal-title":"Can J Cardiol"},{"key":"238_CR31","doi-asserted-by":"crossref","unstructured":"Conly J, Clement F, Tonelli M, Hemmelgarn B, Klarenbach S, Lloyd A et al. Cost-effectiveness of the use of low- and high-potency statins in people at low cardiovascular risk. CMAJ. 2011;183(16):E1180\u2013E1188. Date of Publication: 08 Nov 2011.","DOI":"10.1503\/cmaj.101281"}],"container-title":["Molecular Diagnosis &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-016-0238-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40291-016-0238-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-016-0238-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T08:33:44Z","timestamp":1589704424000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40291-016-0238-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,31]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["238"],"URL":"https:\/\/doi.org\/10.1007\/s40291-016-0238-8","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,31]]}}}